Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

University of Vermont

Overview

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Masking

NONE

Conditions

Interventions

BuprenorphineDRUG

Eligibility

Sex: ALLMin age: 23 YearsMax age: 47 Years

Medical Language ↔ Plain English

Please contact site for information.

Locations (1)

Treatment Research Center

Burlington, Vermont, United States

Outcomes

Primary Outcomes

Drug use

Retention

Weeks abstinent

Weeks continuous abstinence

Overall treatment outcome

Opioid dependence and psychiatric status

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.